Vicarious Surgical (NYSE:RBOT) & Sanara MedTech (NASDAQ:SMTI) Critical Contrast

Vicarious Surgical (NYSE:RBOTGet Rating) and Sanara MedTech (NASDAQ:SMTIGet Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Valuation & Earnings

This table compares Vicarious Surgical and Sanara MedTech’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Vicarious Surgical N/A N/A -$35.21 million N/A N/A
Sanara MedTech $24.14 million 7.47 -$7.92 million ($1.32) -17.13

Sanara MedTech has higher revenue and earnings than Vicarious Surgical.

Insider and Institutional Ownership

35.3% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 4.4% of Sanara MedTech shares are owned by institutional investors. 59.2% of Sanara MedTech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations for Vicarious Surgical and Sanara MedTech, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vicarious Surgical 0 1 3 0 2.75
Sanara MedTech 0 0 1 0 3.00

Vicarious Surgical currently has a consensus target price of $12.75, suggesting a potential upside of 230.31%. Sanara MedTech has a consensus target price of $45.00, suggesting a potential upside of 99.03%. Given Vicarious Surgical’s higher probable upside, research analysts clearly believe Vicarious Surgical is more favorable than Sanara MedTech.

Profitability

This table compares Vicarious Surgical and Sanara MedTech’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Vicarious Surgical N/A -116.85% -29.32%
Sanara MedTech -36.63% -31.14% -26.84%

Volatility and Risk

Vicarious Surgical has a beta of -0.35, indicating that its stock price is 135% less volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500.

Summary

Sanara MedTech beats Vicarious Surgical on 7 of the 11 factors compared between the two stocks.

Vicarious Surgical Company Profile (Get Rating)

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Sanara MedTech Company Profile (Get Rating)

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Want More Great Investing Ideas?

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.